Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADALIMUMAB vs OCRELIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ADALIMUMAB vs OCRELIZUMAB: Safety Overview

Metric ADALIMUMAB OCRELIZUMAB
Total FAERS Reports 499,856 56,186
Deaths Reported 21,807 1,406
Death Rate 4.4% 2.5%
Hospitalizations 108,264 10,364
Average Patient Age 50.9 yrs 47.2 yrs
% Female Patients 67.6% 72.5%
Manufacturer Coherus BioSciences Inc Genentech, Inc.
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status Prescription Prescription